Hyperkalemia Drugs Market- 38% of Growth to Originate from North America| |Evolving Opportunities with AdvaCare International & Ardelyx Inc |17000+ Technavio Reports
Hyperkalemia Drugs Market- 38% of Growth to Originate from North America| |Evolving Opportunities with AdvaCare International & Ardelyx Inc |17000+ Technavio Reports
NEW YORK, April 6, 2022 /PRNewswire/ -- The Hyperkalemia Drugs Market offers a comprehensive analysis of new product launches, the latest trends, drivers, and challenges. The hyperkalemia drugs market value is anticipated to grow by USD 803.17 million from 2021 to 2026 progressing at a CAGR of 18.65% as per the latest market report by Technavio. 38% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for the hyperkalemia drugs market in North America. Market growth in this region will be faster than the growth of the market in ROW. The increasing prevalence of chronic kidney diseases and heart failure caused by the growing sedentary lifestyle will facilitate the hyperkalemia drugs market growth in North America over the forecast period.
紐約，2022年4月6日/美通社/--高鉀血癥藥物市場提供對新產品推出、最新趨勢、驅動因素和挑戰的全面分析。預計高鉀血癥藥品市場價值將增長8.0317億美元 從2021年到2026年，以複合年增長率為18.65%根據Technavio的最新市場報告。38%的市場增長將來自北美在預測期內。美國和加拿大是#年高鉀血癥藥物市場的主要市場。北美。這一地區的市場增長將連續快於市場的增長。由於久坐不動的生活方式導致的慢性腎臟疾病和心力衰竭日益普遍，這將在預測期內促進北美地區高鉀血癥藥物市場的增長。
For more insights on the market share of various regions - Download a free sample now!
有關各地區市場份額的更多信息，請立即下載免費樣本！
Market Dynamics
市場動態
Factors such as growing cases of chronic diseases, the growing use of various therapeutics, and the increasing prevalence of hyperkalemia will drive the growth of the Hyperkalemia Drugs Market. However, poor diagnosis might hamper the market growth. The holistic analysis of the drivers & challenges will help in deducing end goals and refining marketing strategies to gain a competitive edge.
諸如以下因素慢性病病例不斷增加，各種治療方法的使用越來越多，高鉀血癥的患病率也越來越高將推動高鉀血癥藥物市場的增長。然而，診斷不佳可能會阻礙市場增長。對驅動因素和挑戰的全面分析將有助於推斷最終目標和完善營銷戰略，以獲得競爭優勢。
Company Profiles
公司概況
The hyperkalemia drugs market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market. The hyperkalemia drugs market report includes information on the product launches, sustainability, and prospects of leading vendors including AdvaCare International, Ardelyx Inc., AstraZeneca Plc, CytoSorbents Corp., KVK Tech Inc., Sanofi SA, Steadfast MediShield Pvt. Ltd., and Vifor Pharma Management Ltd.
高鉀血癥藥物市場集中供應商正在部署有機和無機增長戰略，以在市場上競爭。高鉀血癥藥物市場報告包括領先供應商的產品推出、可持續性和前景的信息，這些供應商包括AdvaCare國際公司、Ardelyx公司、阿斯利康公司、CytoSorbents公司、KVK技術公司、賽諾菲安萬特、Steadfast MediShield Pvt.Ltd.和Vifor製藥管理有限公司。
Few companies with their key offerings
很少有公司提供關鍵產品
- AdvaCare International - The company offers hyperkalemia drugs as relief in antagonizing the cardiac toxicity provided the patient is not receiving digitalis therapy, under the brand name CalcoCare.
- Ardelyx Inc. - The company offers a hyperkalemia drug that targets potassium secretion through the lumen of the gut, which is still in development under RDX013.
- AstraZeneca Plc - The company offers a hyperkalemia drug that provides rapid and sustained potassium control for patients, under the brand name Lokelma.
- CytoSorbents Corp. - The company offers a hyperkalemia drug designed to treat cases of moderate to severe hyperkalemia where dialysis is not available, under the brand name Kontrol.
- KVK Tech Inc. - The company offers hyperkalemia drugs such as sodium polystyrene sulfonate powder, under the brand name Kayexalate.
- To know about all major vendors with their key offerings - Download a free sample now!
- AdvaCare International-該公司提供高鉀血癥藥物作為對抗心臟毒性的緩解藥物，前提是患者不接受洋地黃治療，品牌為Cthercare。
- Ardelyx Inc.-該公司提供一種高鉀血癥藥物，目標是通過腸腔分泌鉀，該藥物仍在RDX013的開發中。
- 阿斯利康-該公司提供一種高鉀血癥藥物，為患者提供快速和持續的鉀控制，品牌為Lokelma。
- CytoSorbents Corp.-該公司提供一種高鉀血癥藥物，旨在治療無法進行透析的中到重度高鉀血癥病例，品牌為Kontrol。
- KVK科技公司-該公司提供高鉀血癥藥物，如聚苯乙烯磺酸鈉粉末，品牌為Kayexalate。
- 要了解所有主要供應商及其主要產品-現在就下載免費樣本吧！
Competitive Analysis
競爭分析
The competitive scenario provided in the hyperkalemia drugs market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
高鉀血癥藥物市場報告中提供的競爭情景基於各種業績指標對公司進行分析、評估和定位。本分析考慮的一些因素包括公司過去幾年的財務業績、增長戰略、產品創新、新產品的推出、投資、市場份額的增長等。
Market Segmentation
市場細分
- By Type, the market is classified into chronic hyperkalemia and acute hyperkalemia.
- By Geography, the market is classified as North America, Europe, Asia, and the Rest of the World (ROW).
- 通過打字，市場分為慢性高血鉀和急性高血鉀。
- 通過地理，市場被歸類為北美, 歐洲, 亞洲，和世界其他地區(排)。
To know about the contribution of each segment - Download a free sample now!
要了解每個部分的貢獻-請立即下載免費樣本！
Related Reports -
相關報道-
- The retinal drugs market size has the potential to grow by USD 6.28 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 6.10%. Download a free sample now!
- The schizophrenia drugs market share should rise by USD 957.50 million from 2021 to 2025 at a CAGR of 2.06%. Download a free sample now!
- 這個視網膜藥物市場從2020年到2025年，規模有可能增長62.8億美元，市場增長勢頭將以6.10%的複合年均增長率加速。 現在就下載免費樣本吧！
- 這個精神分裂症藥物市場股價應該會上漲9.575億美元從2021年到2025年，年複合增長率為2.06%。現在就下載免費樣本吧！
|
Hyperkalemia Drugs Market Scope | |
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 18.65% |
|
Market growth 2022-2026 |
USD 803.17 million |
|
Market structure |
Concentrated |
|
YoY growth (%) |
18.08 |
|
Performing market contribution |
North America at 38% |
|
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
|
Companies profiled |
AdvaCare International, Ardelyx Inc., AstraZeneca Plc, CytoSorbents Corp., KVK Tech Inc., Sanofi SA, Steadfast MediShield Pvt. Ltd., and Vifor Pharma Management Ltd. |
|
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period, |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
|
高鉀血癥藥物市場範圍 | |
|
報告覆蓋範圍 |
細節 |
|
頁碼 |
120 |
|
基準年 |
2021 |
|
預測期 |
2022-2026 |
|
增長動能和複合年增長率 |
以18.65%的複合年均增長率加速 |
|
2022-2026年市場增長 |
8.0317億美元 |
|
市場結構 |
集中 |
|
同比增長(%) |
18.08 |
|
業績市場貢獻 |
北美為38% |
|
競爭格局 |
領先公司、競爭戰略、消費者參與範圍 |
|
公司簡介 |
AdvaCare國際公司、阿德萊克斯公司、阿斯利康、CytoSorbents公司、KVK技術公司、賽諾菲安萬特、Steadfast MediShield Pvt.Ltd.和Vifor製藥管理有限公司。 |
|
市場動態 |
母市場分析，市場增長誘因和障礙，快速增長和緩慢增長細分市場分析，COVID 19影響和未來消費者動態，預測期市場狀況分析， |
|
自定義權限 |
如果我們的報告沒有包括您正在尋找的數據，您可以聯繫我們的分析師並定製細分市場。 |
Table of Content
目錄表
1 Executive Summary
1執行摘要
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
- 1.1市場概述
- 圖01：執行摘要-市場概覽圖表
- 圖02：執行摘要-市場概覽數據表
- 圖03：執行摘要--全球市場特徵圖表
- 圖04：執行摘要-按地域劃分的市場圖表
- 圖05：執行摘要-按類型劃分的市場細分圖表
- 圖06：執行摘要-增量增長圖表
- 圖07：執行摘要-增量增長數據表
- 圖08：執行摘要-供應商市場定位圖表
2 Market Landscape
2市場格局
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
- 2.1市場生態系統
- 圖09：母市場
- 圖表10：市場特徵
3 Market Sizing
3市場規模調整
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.1市場定義
- 表11：市場定義中包括的供應商的產品
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.2細分市場分析
- 圖12：細分市場
- 3.3 Market size 2021
- 3.3 2021年市場規模
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
- 3.4市場展望：2021-2026年預測
- 圖表13：2021-2026年全球市場規模及預測圖表(百萬美元)
- 圖表14：2021-2026年全球市場規模及預測數據表(百萬美元)
- 圖表15：全球市場圖表：2021-2026年同比增長(%)
- 圖表16：全球市場數據表：2021-2026年同比增長(%)
4 Five Forces Analysis
四、五力分析
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between2021 and 2026
- 4.1五力總結
- 圖17：五力分析--2021年與2026年的對比
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.2買家的議價能力
- 圖表18：買家議價能力圖表--2021年和2026年關鍵因素的影響
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.3供應商的議價能力
- 圖表19：供應商議價能力--2021年和2026年關鍵因素的影響
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.4新進入者的威脅
- 圖20：新進入者的威脅--2021年和2026年關鍵因素的影響
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.5替補球員的威脅
- 圖21：替代品的威脅--2021年和2026年關鍵因素的影響
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.6競爭威脅
- 圖22：競爭的威脅--2021年和2026年關鍵因素的影響
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
- 4.7市況
- 圖表23：2021年和2026年五股力量行情圖表
5 Market Segmentation by Type
5按類型劃分的市場細分
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.1細分市場
- 圖表24：2021-2026年類型-市場份額圖表(%)
- 圖25：2021-2026年類型-市場份額數據表(%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.2按類型比較
- 圖26：按類型進行比較的圖表
- 圖27：按類型比較的數據表
- 5.3 Chronic hyperkalemia - Market size and forecast 2021-2026
- Exhibit 28: Chart on Chronic hyperkalemia - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Chronic hyperkalemia - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Chronic hyperkalemia - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Chronic hyperkalemia - Year-over-year growth 2021-2026 (%)
- 5.3慢性高鉀血癥--市場規模和2021-2026年預測
- 圖表28：慢性高鉀血癥圖表--市場規模和2021-2026年預測(百萬美元)
- 圖表29：慢性高血鉀數據表--市場規模和2021-2026年預測(百萬美元)
- 圖表30：慢性高鉀血癥圖表--2021-2026年同比增長(%)
- 圖表31：慢性高鉀血癥數據表--2021-2026年同比增長(%)
- 5.4 Acute hyperkalemia - Market size and forecast 2021-2026
- Exhibit 32: Chart on Acute hyperkalemia - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Acute hyperkalemia - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Acute hyperkalemia - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Acute hyperkalemia - Year-over-year growth 2021-2026 (%)
- 5.4急性高血鉀--市場規模和2021-2026年預測
- 圖表32：急性高血鉀--2021-2026年市場規模和預測(百萬美元)
- 圖表33：急性高血鉀數據表--2021-2026年市場規模和預測(百萬美元)
- 圖表34：急性高血鉀--2021-2026年同比增長情況圖表(%)
- 圖表35：急性高血鉀--2021-2026年同比增長情況數據表(%)
- 5.5 Market opportunity by Type
- Exhibit 36: Market opportunity by Type ($ million)
- 5.5按類型劃分的市場機會
- 圖表36：按類型劃分的市場機會(百萬美元)
6 Customer Landscape
6客户環境
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 6.1客户環境概述
- 圖37：價格敏感度、生命週期、客户購物籃、採用率和購買標準分析
7 Geographic Landscape
7地理景觀
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.1地理分段
- 圖表38：2021-2026年按地域劃分的市場份額圖表(%)
- 圖表39：2021-2026年按地域劃分的市場份額數據表(%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.2地理位置比較
- 圖表40：地理對比圖表
- 圖41：地理對比數據表
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.3 北美-市場規模和2021-2026年預測
- 圖42：圖表北美-市場規模和2021-2026年預測(百萬美元)
- 圖43：數據表北美-市場規模和2021-2026年預測(百萬美元)
- 圖44：圖表北美-2021-2026年同比增長(%)
- 圖45：數據表打開北美-2021-2026年同比增長(%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.4 歐洲-市場規模和2021-2026年預測
- 圖46：圖表歐洲-市場規模和2021-2026年預測(百萬美元)
- 圖47：數據表歐洲-市場規模和2021-2026年預測(百萬美元)
- 圖表48：圖表歐洲-2021-2026年同比增長(%)
- 圖49：數據表歐洲-2021-2026年同比增長(%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.5 亞洲-市場規模和2021-2026年預測
- 圖表50：圖表亞洲-市場規模和2021-2026年預測(百萬美元)
- 圖51：數據表亞洲-市場規模和2021-2026年預測(百萬美元)
- 圖52：圖表亞洲-2021-2026年同比增長(%)
- 圖53：數據表亞洲-2021-2026年同比增長(%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.6世界其他地區(ROW)--市場規模和2021-2026年預測
- 圖表54：世界其他地區圖表(行)-2021-2026年市場規模和預測(百萬美元)
- 圖表55：世界其他地區數據表(行)--2021-2026年市場規模和預測(百萬美元)
- 圖表56：2021-2026年世界其他地區同比增長圖表(列)(%)
- 圖表57：世界其他地區(ROW)-2021-2026年同比增長數據表(%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.7美國-2021-2026年市場規模和預測
- 圖表58：美國市場規模和2021-2026年預測圖表(百萬美元)
- 圖表59：美國2021-2026年市場規模及預測數據表(百萬美元)
- 圖表60：美國2021-2026年同比增長圖表(%)
- 圖表61：美國2021-2026年同比增長數據表(%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.8 德國-市場規模和2021-2026年預測
- 圖表62：圖表德國-市場規模和2021-2026年預測(百萬美元)
- 圖63：數據表德國-市場規模和2021-2026年預測(百萬美元)
- 圖表64：圖表德國-2021-2026年同比增長(%)
- 圖65：數據表德國-2021-2026年同比增長(%)
- 7.9 Canada - Market size and forecast 2021-2026
- Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.9 加拿大-市場規模和2021-2026年預測
- 圖表66：圖表加拿大-市場規模和2021-2026年預測(百萬美元)
- 圖67：數據表加拿大-市場規模和2021-2026年預測(百萬美元)
- 圖表68：圖表加拿大-2021-2026年同比增長(%)
- 圖69：數據表加拿大-2021-2026年同比增長(%)
- 7.10 France - Market size and forecast 2021-2026
- Exhibit 70: Chart on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on France - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on France - Year-over-year growth 2021-2026 (%)
- 7.10 法國-市場規模和2021-2026年預測
- 圖表70：圖表法國-市場規模和2021-2026年預測(百萬美元)
- 圖71：數據表法國-市場規模和2021-2026年預測(百萬美元)
- 圖72：圖表法國-2021-2026年同比增長(%)
- 圖73：數據表法國-2021-2026年同比增長(%)
- 7.11 UK - Market size and forecast 2021-2026
- Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.11英國-市場規模和2021-2026年預測
- 圖表74：英國市場規模和2021-2026年預測圖表(百萬美元)
- 圖表75：英國市場規模數據表及2021-2026年預測(百萬美元)
- 圖表76：英國2021-2026年同比增長圖表(%)
- 圖表77：英國2021-2026年同比增長數據表(%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
- 7.12按地理位置劃分的市場機會
- 圖78：按地理位置劃分的市場機會(百萬美元)
8 Drivers, Challenges, and Trends
8個驅動因素、挑戰和趨勢
- 8.1 Market drivers
- 8.1市場驅動因素
- 8.2 Market challenges
- 8.2市場挑戰
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
- 8.3驅動因素和挑戰的影響
- 圖79：2021年和2026年驅動因素和挑戰的影響
- 8.4 Market trends
- 8.4市場趨勢
9 Vendor Landscape
9供應商情況
- 9.1 Overview
- 9.1概述
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.2供應商景觀
- 圖80：關於投入的關鍵程度和差異化因素的概覽
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.3景觀破壞
- 圖表81：中斷因素概覽
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
- 9.4行業風險
- 圖表82：關鍵風險對業務的影響
10 Vendor Analysis
10供應商分析
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.1涵蓋的供應商
- 圖表83：涵蓋的供應商
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.2供應商的市場定位
- 圖84：關於供應商地位和分類的矩陣
- 10.3 AdvaCare International
- Exhibit 85: AdvaCare International - Overview
- Exhibit 86: AdvaCare International - Product / Service
- Exhibit 87: AdvaCare International - Key offerings
- 10.3 AdvaCare International
- 圖表85：AdvaCare International-概覽
- 附件86：AdvaCare International-產品/服務
- 圖表87：AdvaCare International-主要產品
- 10.4 Ardelyx Inc.
- Exhibit 88: Ardelyx Inc. - Overview
- Exhibit 89: Ardelyx Inc. - Business segments
- Exhibit 90: Ardelyx Inc. - Key news
- Exhibit 91: Ardelyx Inc. - Key offerings
- Exhibit 92: Ardelyx Inc. - Segment focus
- 10.4 Ardelyx Inc.
- 圖表88：Ardelyx Inc.-概覽
- 圖89：Ardelyx Inc.-業務部門
- 展品90：Ardelyx Inc.-主要新聞
- 展示91：Ardelyx Inc.-主要產品
- 圖表92：Ardelyx Inc.-細分市場焦點
- 10.5 AstraZeneca Plc
- Exhibit 93: AstraZeneca Plc - Overview
- Exhibit 94: AstraZeneca Plc - Product / Service
- Exhibit 95: AstraZeneca Plc - Key news
- Exhibit 96: AstraZeneca Plc - Key offerings
- 10.5阿斯利康
- 圖93：阿斯利康-概覽
- 圖94：阿斯利康--產品/服務
- 證物95：阿斯利康--重點新聞
- 展品96：阿斯利康--主要產品
- 10.6 CytoSorbents Corp.
- Exhibit 97: CytoSorbents Corp. - Overview
- Exhibit 98: CytoSorbents Corp. - Business segments
- Exhibit 99: CytoSorbents Corp. - Key news
- Exhibit 100: CytoSorbents Corp. - Key offerings
- Exhibit 101: CytoSorbents Corp. - Segment focus
- 10.6 CytoSorbents Corp.
- 展品97：CytoSorbents Corp.-概覽
- 圖98：CytoSorbents Corp.--業務板塊
- 展品99：CytoSorbents Corp.-關鍵新聞
- 展品100：CytoSorbents Corp.-主要產品
- 展覽101：CytoSorbents Corp.-細分市場焦點
- 10.7 KVK Tech Inc.
- Exhibit 102: KVK Tech Inc. - Overview
- Exhibit 103: KVK Tech Inc. - Business segments
- Exhibit 104: KVK Tech Inc. - Key offerings
- Exhibit 105: KVK Tech Inc. - Segment focus
- 10.7 KVK Tech Inc.
- 圖102：KVK Tech Inc.-概覽
- 圖103：KVK Tech Inc.-業務細分
- 圖104：KVK Tech Inc.-主要產品
- 圖105：KVK Tech Inc.-細分市場焦點
- 10.8 Sanofi SA
- Exhibit 106: Sanofi SA - Overview
- Exhibit 107: Sanofi SA - Business segments
- Exhibit 108: Sanofi SA - Key news
- Exhibit 109: Sanofi SA - Key offerings
- Exhibit 110: Sanofi SA - Segment focus
- 10.8賽諾菲安萬特
- 圖106：賽諾菲安萬特-概覽
- 圖107：賽諾菲安萬特-商業細分市場
- 圖108：賽諾菲安萬特--重點新聞
- 圖109：賽諾菲安萬特--主要產品
- 圖110：賽諾菲安萬特-細分市場焦點
- 10.9 Steadfast MediShield Pvt. Ltd.
- Exhibit 111: Steadfast MediShield Pvt. Ltd. - Overview
- Exhibit 112: Steadfast MediShield Pvt. Ltd. - Business segments
- Exhibit 113: Steadfast MediShield Pvt. Ltd. - Key offerings
- Exhibit 114: Steadfast MediShield Pvt. Ltd. - Segment focus
- 10.9 Steadfast MediShield Pvt.Ltd.
- 圖111：堅固的MediShield Pvt.Ltd.-概述
- 圖112：堅固的MediShield Pvt.Ltd.-業務細分市場
- 圖113：堅固的MediShield Pvt.Ltd.-主要產品
- 圖114：堅固的MediShield Pvt.Ltd.-細分市場焦點
- 10.10 Vifor Pharma Management Ltd.
- Exhibit 115: Vifor Pharma Management Ltd. - Overview
- Exhibit 116: Vifor Pharma Management Ltd. - Business segments
- Exhibit 117: Vifor Pharma Management Ltd. - Key news
- Exhibit 118: Vifor Pharma Management Ltd. - Key offerings
- Exhibit 119: Vifor Pharma Management Ltd. - Segment focus
- 10.10維福醫藥管理有限公司
- 圖115：Vifor Pharma Management Ltd.-概覽
- 圖116：Vifor Pharma Management Ltd.-業務部門
- 圖117：Vifor Pharma Management Ltd.-主要新聞
- 圖118：Vifor Pharma Management Ltd.-主要產品
- 圖119：Vifor Pharma Management Ltd.-細分市場焦點
11 Appendix
11附錄
- 11.1 Scope of the report
- 11.1報告的範圍
- 11.2 Inclusions and exclusions checklist
- Exhibit 120: Inclusions checklist
- Exhibit 121: Exclusions checklist
- 11.2包括和排除清單
- 圖120：包含物清單
- 圖121：排除清單
- 11.3 Currency conversion rates for US$
- Exhibit 122: Currency conversion rates for US$
- 11.3美元的貨幣兑換率
- 圖表122：美元的貨幣兑換率
- 11.4 Research methodology
- Exhibit 123: Research methodology
- Exhibit 124: Validation techniques employed for market sizing
- Exhibit 125: Information sources
- 11.4研究方法
- 圖123：研究方法
- 圖124：用於市場規模確定的驗證技術
- 圖125：信息來源
- 11.5 List of abbreviations
- Exhibit 126: List of abbreviations
- 11.5縮略語列表
- 圖126：縮略語列表
About Us
關於我們
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Technavio是一家全球領先的技術研究和諮詢公司。他們的研究和分析側重於新興市場趨勢，並提供可操作的見解，幫助企業識別市場機會並制定有效戰略，以優化其市場地位。Technavio的報告庫擁有500多名專業分析師，由17,000多份報告和報告組成，涵蓋50個國家和地區的800項技術。他們的客户羣包括各種規模的企業，其中包括100多家財富500強公司。不斷增長的客户基礎依賴於Technavio的全面覆蓋、廣泛的研究和可操作的市場洞察力，以確定現有和潛在市場中的機會，並評估它們在不斷變化的市場情景中的競爭地位。
Contact
聯繫人
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]Website:
技術研究
傑西·邁達
媒體與營銷主管
美國：+1 844 364 1100
英國：+44 203 893 3200
電子郵件：[受電子郵件保護]網站：
SOURCE Technavio
來源技術
譯文內容由第三人軟體翻譯。